This live event takes place Sunday, June 29, 12 pm-4 pm EDT (9 am-1 pm PDT).
This course is designed to provide an overview into aspects of the older adult population as a cohort, understanding of different types of dementias, and thorough insight into the different cognitive assessment tools. It should be noted that these assessment tools vary based on symptoms and input from patient caregivers, and they are not necessarily diagnostic tools; rather they are tools that can unveil potential signs and symptoms of dementia and prompt the need for additional testing and examination by trained healthcare professionals. Learners will be able to identify types of dementia and the need to discern how to treat the patient most effectively in a safe, dignified manner with appropriate support, if necessary. Other aspects of this course include insights into preventive care and healthy lifestyle choices.
This live webinar is designed for mental and behavioral health professionals who would benefit from enhanced knowledge and skills related to cognitive assessments for dementia.
The purpose of this course is to providing the knowledge and skills necessary for healthcare professionals to identify symptoms and collaborate with other professionals to diagnose and address symptoms in order to expedite the process of dementia diagnosis and enable patients to address symptoms earlier.
Upon completion of this course, you should be able to:
- Examine aspects of aging and impact of longevity relative to Alzheimer disease and related dementias (ADRDs).
- Identify the impact of dementia on quality of life as it affects management of chronic disease.
- Distinguish types of dementia and their symptoms.
- Identify types of assessments to address specific age-related changes.
- Identify modifiable lifestyle risk factors that can directly impact brain and psychological health.
- Examine the role of primary health care in addressing symptoms of dementia and collaborating for proper diagnosis.
- Distinguish between various cognitive assessment tools for dementia symptoms.
Joy Siegel, EdD, MBA, provides solution-oriented services to seniors and their families by assessing and addressing social determinants of health. Direct services are designed to improve quality of life and address such issues as crisis intervention, aging in place, identifying financial resources, home health, housing, and social services. Joy has also worked with healthcare providers and most recently consulted with AgeWell Global, leading a grant-funded pilot designed to reduce Medicare readmissions at Holy Cross Hospital in Ft. Lauderdale. Joy has participated in research projects that include exploring quality of life and healthcare systems, loneliness, civic reengagement, and cultural competency. Her clients include Nova Southeastern University, Case Western Reserve, Jewish Community Services, and Chrysalis Health. Joy has developed an extensive catalog of continuing education courses for healthcare providers. Her latest courses focus on social determinants of health and partnerships between healthcare systems and community-based organizations. Joy was a fundraising consultant for over 15 years and worked with over 200 nonprofits raising over $300 million. She also created, produced, and hosted Good Work Radio, sponsored by the Office Depot Foundation. Joy has interviewed many celebrated heroes and celebrities and is proud to have interviewed all the U.S. presidents since George H. W. Bush.
Contributing faculty, Joy Siegel, EdD, MBA, has disclosed no relevant financial relationship with any product manufacturer or service provider mentioned.
Kimberly Byrd, EdD, PMSW
Scott Deatherage, PhD
The division planners have disclosed no relevant financial relationship with any product manufacturer or service provider mentioned.
Sarah Campbell
The Director of Development and Academic Affairs has disclosed no relevant financial relationship with any product manufacturer or service provider mentioned.
The purpose of NetCE is to provide challenging curricula to assist healthcare professionals to raise their levels of expertise while fulfilling their continuing education requirements, thereby improving the quality of healthcare.
Our contributing faculty members have taken care to ensure that the information and recommendations are accurate and compatible with the standards generally accepted at the time of publication. The publisher disclaims any liability, loss or damage incurred as a consequence, directly or indirectly, of the use and application of any of the contents. Participants are cautioned about the potential risk of using limited knowledge when integrating new techniques into practice.
It is the policy of NetCE not to accept commercial support. Furthermore, commercial interests are prohibited from distributing or providing access to this activity to learners.
Supported browsers for Windows include Microsoft Internet Explorer 9.0 and up, Mozilla Firefox 3.0 and up, Opera 9.0 and up, and Google Chrome. Supported browsers for Macintosh include Safari, Mozilla Firefox 3.0 and up, Opera 9.0 and up, and Google Chrome. Other operating systems and browsers that include complete implementations of ECMAScript edition 3 and CSS 2.0 may work, but are not supported. Supported browsers must utilize the TLS encryption protocol v1.1 or v1.2 in order to connect to pages that require a secured HTTPS connection. TLS v1.0 is not supported.
The role of implicit biases on healthcare outcomes has become a concern, as there is some evidence that implicit biases contribute to health disparities, professionals' attitudes toward and interactions with patients, quality of care, diagnoses, and treatment decisions. This may produce differences in help-seeking, diagnoses, and ultimately treatments and interventions. Implicit biases may also unwittingly produce professional behaviors, attitudes, and interactions that reduce patients' trust and comfort with their provider, leading to earlier termination of visits and/or reduced adherence and follow-up. Disadvantaged groups are marginalized in the healthcare system and vulnerable on multiple levels; health professionals' implicit biases can further exacerbate these existing disadvantages.
Interventions or strategies designed to reduce implicit bias may be categorized as change-based or control-based. Change-based interventions focus on reducing or changing cognitive associations underlying implicit biases. These interventions might include challenging stereotypes. Conversely, control-based interventions involve reducing the effects of the implicit bias on the individual's behaviors. These strategies include increasing awareness of biased thoughts and responses. The two types of interventions are not mutually exclusive and may be used synergistically.
#9922L: Cognitive Screening for Dementia
This course is designed to provide an overview into aspects of the older adult population as a cohort, understanding of different types of dementias, and thorough insight into the different cognitive assessment tools. It should be noted that these assessment tools vary based on symptoms and input from patient caregivers, and they are not necessarily diagnostic tools; rather they are tools that can unveil potential signs and symptoms of dementia and prompt the need for additional testing and examination by trained healthcare professionals. Learners will be able to identify types of dementia and the need to discern how to treat the patient most effectively in a safe, dignified manner with appropriate support, if necessary. Other aspects of this course include insights into preventive care and healthy lifestyle choices.
1. Arevalo-Rodriguez I, Smailagic N, Roqué-Figuls M, et al. Mini-Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI). Cochrane Database of Systematic Reviews. 2021;7(7):CD010783.
2. Bir SC, Khan MW, Javalkar V, Toledo EG, Kelley RE. Emerging concepts in vascular dementia: a review. Journal of Stroke and Cerebrovascular Diseases. 2021;30(8):105864.
3. Boeve BF, Boxer AL, Kumfor F, Pijnenburg Y, Rohrer JD. Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations. Lancet Neurology. 2022;21(3):258-272.
4. Brodaty H, Pond D, Kemp NM, Luscombe G, Harding L, Berman K, Huppert FA. The GPCOG: a new screening test for dementia designed for general practice. Journal of the American Geriatrics Society. 2002;50(3):530-534.
5. Burton JK, Fearon P, Noel-Storr AH, McShane R, Stott DJ, Quinn TJ. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the detection of dementia within a secondary care setting. Cochrane Database of Systematic Reviews. 2021;7(7):CD010772.
6. Chapman S, Joyce JL, Barker MS, et al. Subjective cognitive decline is more accurate when metamemory is better. Frontiers in Aging Neuroscience. 2022;14:787552.
7. Chun CT, Seward K, Patterson A, Melton A, MacDonald-Wicks L. Evaluation of available cognitive tools used to measure mild cognitive decline: a scoping review. Nutrients. 2021;13(11):3974.
8. Ciccone I. Women Patients and Caregivers Report Greater Impact from Dementia with Lewy Bodies. Available at https://www.neurologylive.com/view/women-patients-caregivers-report-greater-impact-dementia-lewy-bodies.
9. Cui L, Zhang Z, Huang L, Li Q, Yi-Han G, Qi-Hao G. Dual-stage cognitive assessment: a two-stage screening for cognitive impairment in primary care. BMC Psychiatry. 2023;23:1-10.
10. Curiel Cid RE, Crocco EA, Kitaigorodsky M, et al. A novel computerized cognitive stress test to detect mild cognitive impairment. Journal of Prevention of Alzheimer's Disease. 2021;8(2):135-141.
11. Davis DH, Creavin ST, Yip JL, Noel-Storr AH, Brayne C, Cullum S. Montreal Cognitive Assessment for the detection of dementia. Cochrane Database of Systematic Reviews. 2021;7(7):CD010775.
12. Deb A, Thornton JD, Sambamoorth U, Innes K. Direct and indirect cost of managing Alzheimer’s disease and related dementias in the United States. Expert Review of Pharmacoeconomics Outcomes Research. 2017;17(2):189-202.
13. Dening KH. Dementia 1: types, risk factors, and recognising signs and symptoms: NT. Nursing Times. 2023;119:18-23.
14. Dujardin K, Duhem S, Guerouaou N, et al. Validation in French of the Montreal Cognitive Assessment 5-Minute, a brief cognitive screening test for phone administration. Revue Neurologique. 2021;177(8):972-979.
15. Fage BA, Chan CC, Gill SS, et al. Mini-Cog for the detection of dementia within a community setting. Cochrane Database of Systematic Reviews. 2021;7(7):CD010860.
16. Forns J, Danysh HE, McQuay LJ, et al. Clinical outcomes and treatment patterns of older adults with dementia-related psychosis by dementia type in the United States. BMC Geriatrics. 2022;22:1-10.
17. Guo QH, Zhou B, Zhao QH, Wang B, Hong Z. Memory and Executive Screening (MES): a brief cognitive test for detecting mild cognitive impairment. BMC Neurology. 2012;12:119.
18. Hall PA, Burhan AM, MacKillop JC, Duarte D. Next-generation cognitive assessment: combining functional brain imaging, system perturbations and novel equipment interfaces. Brain Research Bulletin. 2023;204:110797.
19. Hsu JH, Liu CC, Chen IW, et al. Efficacy of the visual cognitive assessment test for mild cognitive impairment/mild dementia diagnosis: a meta-analysis. Frontiers in Public Health. 2023;11:1293710.
20. Jia L, Du Y, Chu L, et al. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet: Public Health. 2020;5(12):e661-e671.
21. Julayanont P, Nasreddine ZS. Montreal Cognitive Assessment (MoCA): concept and clinical review. In: Larner AJ (ed). Cognitive Screening Instruments. Springer; 2017.
22. Libon DJ, Delano-Wood L, Bondi MW. Mild cognitive impairment. In: Kreutzer JS, DeLuca J, Caplan B (eds). Encyclopedia of Clinical Neuropsychology. Springer; 2021.
23. Liu Y, Xie B, Li Q, et al. Visual Cognitive Assessment Test: utility of the brief cognitive battery for early screening of cognitive impairment in Chongqing, China. Brain and Behavior. 2024;14(2).
24. Lui L, Zhang Z, Huang L, Li Q, Yi-Han G, Qi-Hao G. Dual-stage cognitive assessment: a two-stage screening for cognitive impairment in primary care. BMC Psychiatry. 2023;23:1-10.
25. Nandi A, Counts N, Bröker J, et al. Cost of care for Alzheimer’s disease and related dementias in the United States: 2016 to 2060. NPJ Aging. 2024;10.
26. Petersen RC, Wiste HJ, Weigand SD, et al. NIA-AA Alzheimer’s Disease Framework: clinical characterization of stages. Annals of Neurology. 2021;89(6):1145-1156.
27. Prasad S, Katta MR, Abhishek S, et al. Recent advances in Lewy body dementia: a comprehensive review. Disease-a-Month. 2023;69(5):101441.
28. Quitoriano J, Hamm RM. In patients suspected of cognitive decline, what is the most accurate in-office screening instrument to determine if there is dementia needing further evaluation and management? Journal of the Oklahoma State Medical Association. 2017;110(8):454-457.
29. Sanders AE, School C, Kalish VB. Vascular Dementia. Available at https://www.ncbi.nlm.nih.gov/books/NBK430817.
30. Scheltens P, De Strooper B, Kivipelto M, et al. Alzheimer's disease. Lancet. 2021;397(10284):1577-1590.
31. Schmidt K. Clinical dementia rating scale. In: Maggino F (ed). Encyclopedia of Quality of Life and Well-Being Research. Springer; 2021.
32. Seitz DP, Chan CC, Newton HT, et al. Mini-Cog for the diagnosis of Alzheimer’s disease dementia and other dementias within a primary care setting. Cochrane Database of Systematic Reviews. 2018;2(2):CD011415.
33. Siddiqui M, Nyahoda T, Traber C, et al. Screening for cognitive impairment in primary care: rationale and tools. Missouri Medicine. 2023;120(6):431-439.
34. Sideman AB, Ma M, Hernandez de Jesus A. Primary care practitioner perspectives on the role of primary care in dementia diagnosis and care. JAMA Network Open. 2023;6(9):e2336030.
Mention of commercial products does not indicate endorsement.